References
- Gardner MO, Owen J, Skelly S, et al. Preterm delivery after indomethacin. A risk factor for neonatal complications? J Reprod Med. 1996;41(12):903–906.
- Klauser CK, Briery CM, Keiser SD, et al. Effect of antenatal tocolysis on neonatal outcomes. J Matern Fetal Neonatal Med. 2012;25(12):2778–2781.
- Macones GA, Marder SJ, Clothier B, et al. The controversy surrounding indomethacin for tocolysis. Am J Obstet Gynecol. 2001;184(3):264–272.
- Gordon PV, Swanson JR, Clark R. Antenatal indomethacin is more likely associated with spontaneous intestinal perforation rather than NEC. Am J Obstet Gynecol. 2008;198(6):725; author reply 725–6.
- Amin SB, Sinkin RA, Glantz JC. Metaanalysis of the effect of antenatal indomethacin on neonatal outcomes. Am J Obstet Gynecol. 2007;197(5):486.e1–486.10.
- Hammers AL, Sanchez-Ramos L, Kaunitz AM. Antenatal exposure to indomethacin increases the risk of severe intraventricular hemorrhage, necrotizing enterocolitis, and periventricular leukomalacia: a systematic review with metaanalysis. Am J Obstet Gynecol. 2015;212(4):505–513.
- Norton ME, Merrill J, Cooper BA, et al. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med. 1993;329(22):1602–1607.
- Dutta EH, Behnia F, Harirah H, et al. Perinatal outcomes after short versus prolonged indomethacin for tocolysis in women with preterm labor. Amer J Perinatol. 2016;33(09):844–848.
- Nishikubo T, Takahashi Y, Nakagawa Y, et al. Renal impairment in very low birthweight infants following antenatal indomethacin administration. Acta Paediatr Jpn. 1994;36(2):202–206. Apr
- Kirshon B, Moise KJ, Jr., Mari G, et al. Long-term indomethacin therapy decreases fetal urine output and results in oligohydramnios. Am J Perinatol. 1991;8(2):86–88.
- Uslu T, Ozcan FS, Aydin C. Oligohydramnios induced by maternal indomethacin therapy. Int J Clin Pharmacol Ther Toxicol. 1992;30(7):230–232.
- Sandruck JC, Grobman WA, Gerber SE. The effect of short-term indomethacin therapy on amniotic fluid volume. Am J Obstet Gynecol. 2005;192(5):1443–1445.
- Hill LM, Lazebnik N, Many A. Effect of indomethacin on individual amniotic fluid indices in multiple gestations. J Ultrasound Med. 1996;15(5):395–399.
- Jetton JG, Boohaker LJ, Sethi SK, et al. Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study. Lancet Child Adolesc Health. 2017;1(3):184–194.
- Cuzzolin L, Fanos V, Pinna B, et al. Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions. Pediatr Nephrol. 2006;21(7):931–938. Jul
- Harris RC. Jr. Cyclooxygenase-2 inhibition and renal physiology. Am J Cardiol. 2002;89(6a):10d–17d.
- Carmody JB, Harer MW, Denotti AR, et al. Caffeine exposure and risk of acute kidney injury in a retrospective cohort of very low birth weight neonates. J Pediatr. 2016;172:63–68.e1. 01/
- Harer MW, Askenazi DJ, Boohaker LJ, et al. Association between early caffeine citrate administration and risk of acute kidney injury in preterm neonates: results from the AWAKEN study. JAMA Pediatr. 2018;172(6):e180322.
- Lee CC, Chan OW, Lai MY, et al. Incidence and outcomes of acute kidney injury in extremely-low-birth-weight infants. PLoS One. 2017;12(11):e0187764.